查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2006306

內視鏡黏膜下剝離術市場：2026-2032年全球市場預測（依產品類型、手術類型、適應症、疾病及最終用戶分類）

Endoscopic Submucosal Dissection Market by Product, Procedure Type, Indication Type, Disease Condition, End-User Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，內視鏡黏膜下剝離術 (ESD) 市值將達到 4.366 億美元，到 2026 年將成長至 4.6196 億美元，到 2032 年將達到 6.629 億美元，年複合成長率為 6.14%。

主要市場統計數據
基準年 2025 4.366億美元
預計年份：2026年 4.6196億美元
預測年份 2032 6.629億美元
複合年成長率 (%) 6.14%

內視鏡黏膜下剝離術（ESD）作為微創胃腸道介入領域的突破性進展，最初起源於東亞，並逐漸在歐洲和美國普及。此技術能夠完整切除黏膜下層的早期腫瘤病變，從而最大限度地減少手術創傷，同時最佳化組織病理學評估。醫學界高度重視ESD無與倫比的精準性，使其成為早期胃腸道癌症和某些癌前病變治療的重要治療方法。內視鏡成像技術、電外科系統整合以及內視鏡操作性的現代進步，共同提高了手術安全性，並拓展了其適應症，使其不再局限於最初的胃癌治療。

隨著技術的日趨成熟，涵蓋胃腸病學、外科腫瘤學和生物醫學工程等多學科領域的專業知識融合，推動了器械設計和操作者技能的持續改進。如今，領先的醫療中心普遍採用基於模擬的培訓模組、導師制專案和結果登記系統，以縮短學習曲線並規範臨床通訊協定。這些協作框架加速了ESD在全球的普及，使其從小眾創新發展成為先進治療性內視鏡的基石。在此背景下，包括醫療服務提供者、醫療設備製造商和保險報銷機構在內的各利益相關人員，仍在不斷尋求在臨床療效、降低手術成本和擴大患者就醫範圍之間取得平衡。

變革性創新、協作培訓和以患者為中心的進步正在重新定義流程標準。

內視鏡黏膜下剝離術 (ESD) 領域正經歷著模式轉移，這主要得益於器械和成像技術的不斷創新。近年來，刀具技術的改進，例如絕緣刀尖、雙刀尖和三角刀尖等設計，顯著提高了切除精度，同時降低了黏膜下穿孔的風險。同時，高清內視鏡成像與窄頻成像和共聚焦雷射內視鏡等即時組織分析技術的結合，使臨床醫生能夠以前所未有的精度識別病變邊界。此外，人工智慧驅動的決策支援系統也為這些技術進步提供了有力支持，它們能夠輔助病變分割和電外科參數最佳化，從根本上改變了手術流程和治療效果。

2025 年美國關稅調整對醫療設備採購和臨床實務的影響。

2025年，美國實施了一系列針對進口醫療設備和內視鏡黏膜下剝離術（ESD）關鍵零件的關稅調整。這些調整給整個供應鏈帶來了隱性的成本壓力，尤其是在先進的電外科設備、專用供氣設備和高解析度內視鏡領域。醫院和門診診所正在考慮調整採購慣例，例如供應商多元化和主動重新談判契約，以減輕整體成本上升的影響。同時，製造商也在重組供應鏈，探索近岸外包的機會，並最佳化零件採購，以保持價格競爭力，確保臨床醫生能夠獲得最先進的設備。

基於產品創新、流程變化、臨床適應症、病理分類和通路參與的市場區隔策略分析。

內視鏡黏膜下剝離術 (ESD) 市場可透過檢驗輔助設備和核心內視鏡系統的產品創新進行分析。輔助設備包括帽罩組件、鉗子和夾子、注射針、充氣裝置、各種刀具亞型和套管針。即使在刀具類別內部，具有雙頭、軟性頭、鉤狀頭、絕緣頭和三角形頭的器械也針對特定的組織紋理和病變形狀進行了性能最佳化。內視鏡系統進一步細分為大腸鏡、十二指腸鏡和胃鏡，每種系統都有其自身的人體工學和光學配置，這些配置會影響手術效率和臨床醫生的偏好。

這份文件揭示了全球市場的區域採用趨勢、償還框架和創新軌跡。

在美洲，完善的醫療基礎設施和成熟的醫療保險報銷體系為內視鏡黏膜下剝離術（ESD）的廣泛應用奠定了堅實的基礎。美國和加拿大的頂尖醫療中心在手術量方面處於領先地位，並發表了重要的臨床證據，從而增強了相關人員的信心。支持先進內視鏡介入治療的政策環境使保險公司能夠認知到微創病變切除術帶來的長期成本節約，這反過來又鼓勵了更多患者接受治療，並促進了醫療保健對尖端設備的投入。

構成永續發展教育生態系統的關鍵相關人員的競爭格局和策略趨勢

一群全球醫療技術領導企業和創新專家正在重塑內視鏡黏膜下剝離術 (ESD) 市場的競爭格局。成熟的主要企業正透過產品改進不斷強化自身實力，為先進的刀型和符合人體工學設計的內視鏡獲取智慧財產權，並利用全球分銷網路擴大市場滲透率。同時，Start-Ups的新創公司正透過推出人工智慧驅動的病變檢測軟體和旨在簡化手術流程的新一代空氣充氣技術而迅速崛起。

具有前瞻性的策略和協作舉措，以推動創新、市場滲透和永續成長。

為了充分掌握內視鏡黏膜下剝離術快速成長的機遇，產業領導者必須優先發展跨領域夥伴關係，整合臨床、監管和商業方面的專業知識。優先投資研發配備自適應回饋機制的新一代電外科設備，將有助於產品線差異化，並應對不斷變化的臨床挑戰。同時，建立整合虛擬實境模擬器和認證訓練計畫的綜合訓練體系，將確保手術品質的一致性，並縮短新興市場的推廣應用週期。

嚴謹的多模態研究框架，整合了原始調查、二手資料和分析三角測量。

本執行執行摘要依據的研究是透過精心結合一手和二手調查資料而完成的。研究人員與關鍵意見領袖 (KOL) 和內視鏡醫師進行了結構化訪談和諮詢研討會，以深入觀點內視鏡黏膜下剝離術的臨床工作流程、技術應用障礙以及未滿足的需求。除這些定性研究結果外，研究人員還廣泛查閱了同行評審期刊、臨床試驗註冊資料和會議論文集，檢驗不斷發展的最佳實踐和新型醫療設備的效能資料。

整合核心洞察與未來展望，為決策者提供支持，並鞏固市場領導地位。

本執行摘要闡述了技術創新、不斷變化的監管環境以及市場動態之間錯綜複雜的相互作用，這些因素共同塑造了內視鏡黏膜下剝離術 (ESD) 領域。主要結論強調了先進刀具設計、精密成像技術和人工智慧驅動的決策支援工具對手術有效性和安全性的關鍵影響。同時，費用調整和不斷變化的報銷環境也要求制定靈活的籌資策略並積極與相關人員溝通。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 內視鏡黏膜下剝離術市場：依產品分類

  • 配件
    • 帽子
    • 鑷子和夾子
    • 注射針
    • 供氣設備
    • 刀
      • 雙重的
      • 彈性
      • 鉤
      • 帶絕緣尖端
      • 三角形尖端
    • 套管針
  • 內視鏡設備
    • 大腸鏡檢查
    • 十二指腸內視鏡檢查
    • 胃鏡檢查

第9章 內視鏡黏膜下剝離術市場（依手術類型分類）

  • 全層切除
  • 混合型靜電放電
  • 部分厚度切除

第10章：內視鏡黏膜下剝離術市場（依適應症分類）

  • 結腸癌
  • 食道癌
  • 胃癌

第11章 依疾病分類的內視鏡黏膜下剝離術市場

  • 良性腫瘤
  • 惡性腫瘤
    • 侵入性
    • 非侵入性

第12章 內視鏡黏膜下剝離術市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第13章 內視鏡黏膜下剝離術市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 內視鏡黏膜下剝離術市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 內視鏡黏膜下剝離術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國內視鏡黏膜下剝離術市場

第17章：中國內視鏡黏膜下剝離術市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • Beijing ZKSK Technology Co., Ltd.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Erbe Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Hoya Corporation
  • Huger Medical Instrument Co., Ltd.
  • Interscope, Inc.
  • Jiangsu Vedkang Medical Science and Technology Co., Ltd.
  • Karl Storz SE & Co. KG
  • Leo Medical Co. Ltd.
  • Medi-Globe GmbH by DCC Healthcare
  • Medtronic PLC
  • Micro-Tech Endoscopy
  • Mizuho America, Inc.
  • MTW-Endoskopie W. Haag KG
  • Olympus Corporation
  • Ovesco Endoscope AG
  • Richard Wolf GmbH
  • SonoScape Medical Corp.
  • Steris Corporation
  • Sumitomo Bakelite Co., Ltd.
  • Zeon Medical Inc.
Product Code: MRR-F611BFBC6402

The Endoscopic Submucosal Dissection Market was valued at USD 436.60 million in 2025 and is projected to grow to USD 461.96 million in 2026, with a CAGR of 6.14%, reaching USD 662.90 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 436.60 million
Estimated Year [2026] USD 461.96 million
Forecast Year [2032] USD 662.90 million
CAGR (%) 6.14%

Endoscopic Submucosal Dissection (ESD) emerged as a groundbreaking advancement in minimally invasive gastrointestinal interventions, initially pioneered in East Asia and progressively embraced by Western markets. This technique offers the capacity to achieve en bloc resection of early-stage neoplastic lesions within the submucosal layer, thereby minimizing procedural invasiveness while optimizing histopathological assessment. The clinical community has recognized ESD for its unparalleled precision, making it indispensable for managing early gastrointestinal cancers and select premalignant conditions. Contemporary enhancements in endoscopic imaging, electrosurgical system integration, and scope maneuverability have collectively elevated procedural safety profiles and expanded therapeutic indications beyond the initial gastric focus.

As the technology matures, a convergence of multidisciplinary expertise spanning gastroenterology, surgical oncology, and biomedical engineering has driven iterative improvements in instrument design and operator competency. Centers of excellence now routinely incorporate simulation-based training modules, proctorship programs, and outcome registries to streamline learning curves and standardize clinical protocols. These collaborative frameworks have accelerated global adoption, enabling ESD to transition from a niche innovation to a cornerstone in advanced therapeutic endoscopy. Against this backdrop, stakeholders across healthcare delivery, device manufacturing, and reimbursement agencies continue to navigate the balance between clinical efficacy, procedural cost containment, and broadening patient access.

Transformative Innovations, Collaborative Training, and Patient-Centered Advances Redefining Procedural Standards

The landscape of Endoscopic Submucosal Dissection is undergoing a paradigm shift driven by relentless innovation in instrumentation and imaging modalities. Recent refinements in knife technology, including insulation-tipped, dual, and triangle-tipped designs, have significantly enhanced resection precision while mitigating the risk of submucosal perforation. Simultaneously, the integration of high-definition endoscopic visualization and real-time tissue characterization through narrow-band imaging and confocal laser endomicroscopy has empowered clinicians to delineate lesion boundaries with unprecedented accuracy. These technological leaps are complemented by AI-enabled decision support systems that assist in lesion segmentation and electrosurgical parameter optimization, fundamentally altering procedural workflows and outcomes.

Equally transformative are the evolving training paradigms that prioritize competency-based progression and simulation-driven skill acquisition. Virtual reality simulators and ex vivo tissue models now replicate the tactile nuances of tissue dissection, allowing trainees to refine hand-eye coordination and complication management in a risk-free environment. Moreover, cross-institutional mentorship networks and teleproctoring platforms have democratized access to expert guidance, accelerating proficiency in regions previously limited by resource constraints. As a result, procedural adoption curves are flattening, and the global clinician community is advancing toward standardized ESD curricula anchored in rigorous outcome metrics. Collectively, these shifts underscore a patient-centered ethos that prioritizes safety, efficiency, and equitable access as the cornerstones of the next generation of GI therapeutic endoscopy.

Implications of 2025 U.S. Tariff Adjustments on Device Procurement and Clinical Accessibility

In 2025, the United States enacted a series of tariff modifications targeting imported medical devices and accessory components integral to endoscopic submucosal dissection. These adjustments have introduced nuanced cost pressures across the supply chain, particularly for advanced electrosurgical knives, specialized insufflation units, and high-definition endoscopes. Hospitals and outpatient centers are assessing strategic pivots in procurement practices, including supplier diversification and proactive contract renegotiations to mitigate the impact of increased landed costs. Concurrently, manufacturers are reevaluating supply chain configurations, exploring nearshoring opportunities, and optimizing component sourcing to preserve competitive pricing and maintain clinician access to state-of-the-art equipment.

Beyond immediate cost considerations, the tariff landscape is influencing broader research and development priorities. Device innovators are accelerating the design of modular systems that utilize locally sourced components and refining manufacturing processes to reduce dependency on tariff-affected imports. Health systems are likewise undertaking comprehensive budget impact analyses to balance capital expenditures against long-term clinical benefits, with an emphasis on value-based procurement policies. These strategic responses are reshaping the interplay between cost containment and clinical innovation, ultimately defining new benchmarks for market resilience and operational agility in the ESD space.

Strategic Dissection of Market Segmentation by Product Innovations, Procedural Variants, Clinical Indications, Pathological Classifications, and Channel Engagement

The endoscopic submucosal dissection market can be deconstructed by examining product innovations across accessory devices and core endoscopy systems. Accessory devices encompass items such as cap and hood assemblies, forceps and clips, injection needles, insufflation units, various knife subtypes, and trocars. Within the knife category itself, dual, flex, hook, insulation-tipped, and triangle-tipped instruments delineate performance attributes tailored to specific tissue textures and lesion topographies. Endoscopy systems further subdivide into colonoscopes, duodenoscopes, and gastroscopes, each embodying unique ergonomic and optical configurations that influence procedural efficiency and clinician preference.

Procedural modalities range from full-thickness resection techniques that enable complete transmural excision to hybrid approaches that integrate submucosal tunneling with en bloc removal, as well as partial-thickness resections optimized for discrete lesions. These variants have demonstrated varying risk-benefit profiles, informing institutional adoption based on tumor characteristics and operator proficiency. Clinical indications driving ESD adoption include colorectal, esophageal, and gastric cancer, reflecting the epidemiological burden of early-stage neoplastic presentations. Parallel to indication-based segmentation is the classification by disease condition, distinguishing benign tumors from malignant tumors and further stratifying malignant cases into invasive and non-invasive categories. This granularity informs both technology utilization and outcome expectations.

Finally, end-user channels span ambulatory surgical centers, hospitals, and specialty clinics, each presenting distinct procedural volumes, reimbursement frameworks, and investment capacities. Ambulatory surgical centers are gaining traction as efficient venues for straightforward ESD procedures, while tertiary hospitals continue to anchor complex cases and training initiatives. Specialty clinics focused on advanced endoscopy further contribute to the diffusion of technique-specific expertise and high-acuity patient management.

Illuminating Regional Adoption Patterns, Reimbursement Frameworks, and Innovation Trajectories Across Global Markets

In the Americas, robust healthcare infrastructures and well-established reimbursement systems underpin a strong base for endoscopic submucosal dissection adoption. Centers of excellence across the United States and Canada lead in procedural volumes and publish pivotal clinical evidence, reinforcing stakeholder confidence. Policy environments that support advanced endoscopic interventions have enabled payers to recognize the long-term cost savings associated with minimally invasive lesion removal, thereby fostering patient access and institutional investment in cutting-edge devices.

Across Europe, the Middle East, and Africa, regulatory heterogeneity and varying reimbursement pathways create a mosaic of adoption rates. Western European nations with centralized health technology assessment processes have integrated ESD into standard care protocols for indicated lesions, whereas emerging markets within the region are actively building clinical infrastructure and training networks to bridge gaps in procedural expertise. Meanwhile, several Middle Eastern health systems are accelerating capital investments in specialized endoscopy units to position their centers at the forefront of GI oncology treatment.

The Asia-Pacific region continues to be a global leader in procedural innovation and clinical evidence generation, driven by high patient volumes and proactive government initiatives. Countries such as Japan and South Korea remain pioneers in technique refinement, while rapidly developing economies like India and China are scaling training programs and local device manufacturing capacities. Collaborative research consortia and public-private partnerships in the region are further expediting technology transfer and establishing new benchmarks for affordability and access.

Competitive Landscape and Strategic Movements of Leading Stakeholders Shaping the ESD Ecosystem

A cadre of global medtech leaders and specialized innovators defines the competitive contours of the endoscopic submucosal dissection market. Established incumbents are reinforcing their portfolios through incremental product enhancements, securing intellectual property for advanced knife geometries and ergonomic scope designs, and leveraging global distribution networks to broaden market penetration. Simultaneously, agile startups are gaining traction by introducing AI-assisted lesion detection software and next-generation insufflation technologies aimed at streamlining procedural workflows.

Strategic partnerships and collaborations between device manufacturers, academic centers, and contract research organizations have accelerated clinical validation pathways and enhanced regulatory readiness. Moreover, mergers and acquisitions remain a focal strategy for integrating complementary technologies and fortifying intellectual property pipelines. As these developments unfold, leading stakeholders are also prioritizing lifecycle management programs that include reusable component sterilization solutions, subscription-based service models, and digital health platforms designed to monitor post-procedural outcomes.

Overall, the competitive landscape is characterized by a dual imperative: advancing clinical performance while optimizing total cost of ownership. Organizations that successfully align product innovation, service excellence, and data-driven customer support are best positioned to capture value in an increasingly sophisticated ESD environment.

Proactive Strategies and Collaborative Initiatives to Propel Innovation, Market Penetration, and Sustainable Growth

To capitalize on the burgeoning opportunities in endoscopic submucosal dissection, industry leaders must emphasize cross-functional partnerships that bridge clinical, regulatory, and commercial expertise. Prioritizing investment in R&D for next-generation electrosurgical knives with adaptive feedback mechanisms will differentiate product offerings and address evolving clinical challenges. Concurrently, establishing comprehensive training ecosystems that integrate virtual reality simulators and certified proctorship ensures consistent procedural quality and shortens adoption curves for emerging markets.

Engaging with payers and health authorities to demonstrate the value proposition of ESD through real-world evidence and cost-effectiveness analyses will facilitate favorable reimbursement decisions and expand patient access. Diversifying supply chain networks by incorporating regional manufacturing hubs and strategic sourcing initiatives can mitigate tariff-related risks while optimizing inventory turnover. Furthermore, developing digital platforms for perioperative patient engagement and outcome tracking will foster data-driven improvements in clinical protocols and strengthen long-term customer loyalty.

Ultimately, aligning these strategies with sustainable business models-such as service-based agreements and outcome-based reimbursement schemes-will enhance market resilience. By adopting a holistic approach that balances innovation, education, and stakeholder alignment, organizations can secure a leadership position in the evolving ESD ecosystem.

Rigorous Multimodal Research Framework Integrating Primary Inquiry, Secondary Data, and Analytical Triangulation

The research underpinning this executive summary was conducted through a meticulous blend of primary and secondary methodologies. Key opinion leaders and endoscopy specialists were engaged in structured interviews and advisory workshops to capture nuanced perspectives on clinical workflows, technology adoption barriers, and unmet needs in endoscopic submucosal dissection. These qualitative insights were complemented by an extensive review of peer-reviewed journals, clinical trial registries, and conference proceedings to validate evolving best practices and emergent device performance data.

Secondary research included systematic analysis of regulatory filings, patent landscapes, and financial disclosures to map innovation trajectories and competitive positioning. Additionally, a detailed assessment of tariff schedules, reimbursement codes, and health technology assessment reports informed the evaluation of macroeconomic drivers. Quantitative data points were then subjected to triangulation against real-world procedural volumes and market intelligence sources to ensure consistency and reliability. The final deliverables underwent multiple iterations of peer review and methodological audits to confirm the integrity of findings and recommendations.

Synthesis of Core Insights and Future Trajectories to Empower Decision Makers and Foster Market Leadership

This executive summary has elucidated the intricate interplay of technological innovation, regulatory shifts, and market dynamics shaping the endoscopic submucosal dissection domain. Key takeaways underscore the critical impact of advanced knife designs, enhanced imaging modalities, and AI-driven decision support tools on procedural efficacy and safety. Simultaneously, the ramifications of tariff adjustments and evolving reimbursement landscapes necessitate agile sourcing strategies and proactive stakeholder engagement.

Looking ahead, the maturation of competency-based training programs, cross-border collaborations, and localized manufacturing initiatives will accelerate diffusion in underpenetrated markets. The integration of digital health platforms for patient monitoring and outcome analytics promises to refine clinical protocols and bolster evidence generation. As industry leaders align on sustainable business models and engage payers with compelling value narratives, endoscopic submucosal dissection is poised to become a standardized cornerstone of early gastrointestinal cancer management. Decision makers equipped with these insights are well-positioned to navigate complexity, drive innovation, and deliver superior patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopic Submucosal Dissection Market, by Product

  • 8.1. Accessory Devices
    • 8.1.1. Cap & Hood
    • 8.1.2. Forceps & Clips
    • 8.1.3. Injection Needles
    • 8.1.4. Insufflations Units
    • 8.1.5. Knives
      • 8.1.5.1. Dual
      • 8.1.5.2. Flex
      • 8.1.5.3. Hook
      • 8.1.5.4. Insulation-tipped
      • 8.1.5.5. Triangle-tipped
    • 8.1.6. Trocars
  • 8.2. Endoscopy Devices
    • 8.2.1. Colonoscopes
    • 8.2.2. Duodenoscopes
    • 8.2.3. Gastroscopes

9. Endoscopic Submucosal Dissection Market, by Procedure Type

  • 9.1. Full-Thickness Resection
  • 9.2. Hybrid ESD
  • 9.3. Partial-Thickness Resection

10. Endoscopic Submucosal Dissection Market, by Indication Type

  • 10.1. Colorectal Cancer
  • 10.2. Esophageal Cancer
  • 10.3. Gastric Cancer

11. Endoscopic Submucosal Dissection Market, by Disease Condition

  • 11.1. Benign Tumors
  • 11.2. Malignant Tumors
    • 11.2.1. Invasive
    • 11.2.2. Non-Invasive

12. Endoscopic Submucosal Dissection Market, by End-User Type

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Endoscopic Submucosal Dissection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopic Submucosal Dissection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopic Submucosal Dissection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopic Submucosal Dissection Market

17. China Endoscopic Submucosal Dissection Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ambu A/S
  • 18.6. Beijing ZKSK Technology Co., Ltd.
  • 18.7. Boston Scientific Corporation
  • 18.8. ConMed Corporation
  • 18.9. Erbe Elektromedizin GmbH
  • 18.10. Fujifilm Holdings Corporation
  • 18.11. Hoya Corporation
  • 18.12. Huger Medical Instrument Co., Ltd.
  • 18.13. Interscope, Inc.
  • 18.14. Jiangsu Vedkang Medical Science and Technology Co., Ltd.
  • 18.15. Karl Storz SE & Co. KG
  • 18.16. Leo Medical Co. Ltd.
  • 18.17. Medi-Globe GmbH by DCC Healthcare
  • 18.18. Medtronic PLC
  • 18.19. Micro-Tech Endoscopy
  • 18.20. Mizuho America, Inc.
  • 18.21. MTW-Endoskopie W. Haag KG
  • 18.22. Olympus Corporation
  • 18.23. Ovesco Endoscope AG
  • 18.24. Richard Wolf GmbH
  • 18.25. SonoScape Medical Corp.
  • 18.26. Steris Corporation
  • 18.27. Sumitomo Bakelite Co., Ltd.
  • 18.28. Zeon Medical Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 192. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 194. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 199. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 224. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 225. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 228. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 229. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 234. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 238. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)